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ABSTRACT. In eight hyperprolactinemic amenorrheic
women who had a microprolactinoma, LH secretion was exam-
ined by measuring its concentration in blood samples collected
every 15 min for 6 h before and 8 days after successful selective
adenomectomy. Computer analysis was used for LH peak eval-
uation. In both circumstances, serum PRL and basal estradiol
(E2) levels were also determined. Before operation, the number
of LH peaks ranged from zero to one per 6 h in seven patients
and was two per 6 h in the eighth patient. In all patients, serum
PRL was normal on the eighth postoperative day, while E2 levels
remained low, similar to the values usually found in the early
follicular phase of the cycle in normal women. Postoperatively,
mean LH levels were similar to preoperative levels, but there
was a dramatic increase in the number of LH peaks (three to
five per 6 h) in five of the eight patients.
These observations confirm the impairment of LH pulsatility
in hyperprolactinemia and demonstrate that normalization of
PRL levels by surgery can restore LH pulsatile secretion in
certain women as early as the eighth day after operation in the
absence of a significant change in serum E2 levels. Thus, the
preoperative impaired pulsatility of LH secretion was probably
a central effect of hyperprolactinemia. {J Clin Endocrinol Metab
62: 1044, 1986)
THE MAIN disturbances provoked by hyperprolac-tinemia in the human concern the hypothalamo-
pituitary-gonadal axis. In the rats, dopamine turnover in
the median eminence is increased by hyperprolactinemia,
probably by a short loop feedback (1, 2). In man, dopa-
mine infusion reduces serum LH concentrations (3), as
well as the frequency of LH pulses (4). Furthermore,
hyperprolactinemia is associated with a reduction in
frequency or absence of LH pulses (5-8). Normalization
of PRL with bromocriptine is followed by restoration of
LH pulsatility (5-8), but this action may be due to a
central action of bromocriptine rather than a conse-
quence of reduced PRL secretion.
Recently, LH pulsatility was found to be restored after
transsphenoidal surgery (9). However, since that resto-
ration occurred after resumption of menses and normal
ovulatory function, it remained uncertain whether the
postoperative increase in the number of LH peaks was
due to PRL normalization or to an elevation of serum
estradiol (E2) levels. Indeed, the LH positive feedback
response to estrogens is impaired in hyperprolactinemia
(10) and restored after bromocriptine (11).
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The present study was undertaken to determine
whether 1) LH pulsatility is present in women with
microprolactinomas, 2) the pattern of LH secretion is
modified soon after successful adenomectomy, and 3)




This consecutive series was composed of eight women re-
ferred to the Neurosurgical Clinic at the University of Liege
for surgical treatment of their microprolactinomas. Surgery
was undertaken because of lack of efficacy or side-effects of
long term treatment with bromocriptine. All patients (Table 1)
had amenorrhea-galactorrhea, elevated plasma PRL concentra-
tions, and normal thyroid and adrenal function. The presence
of microadenomas was established by sellar polytomography
and high resolution computed tomographic scan. In all patients,
an adenoma was later found by transsphenoidal surgery and
was totally removed. The size of the adenomas was estimated
by measuring the diameter of the cavity after tumorectomy.
None of the patients had any postoperative complications; in
particular, neither diabetes inspidus nor pituitary insufficiency
was recorded.
Methods
The studies of pulsatile LH secretion were performed only
after all patients had given informed written consent. On the
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day after admission, an indwelling cannula was inserted into a
forearm vein at 0800 h, and 5 ml blood were drawn every 15
min for 6 h. The serum was stored at —20 C for LH assays. In
addition, blood samples were obtained for determinations of
basal FSH, PRL, and E2 concentrations on 3 consecutive days.
The protocol was carried out again on the eighth postoperative
day. The patients did not receive any medications during the
sampling periods.
Assays
Serum LH concentrations were determined using slight mod-
ifications of a very specific and sensitive RIA previously de-
scribed (12). The data were analyzed on the basis of a weighted
linear regression using Rodbard's programs (13). The minimum
detectable dose ranged from 0.08-0.4 mlU/ml. The slope of the
standard curve was -1.02 to -1.16, and the ED50 ranged from
2.23-3.61 mlU/ml. In the range of 1-10 mlU/ml (corresponding
to 20-80% bound to free ratio), the intraassay coefficient of
variation ranged from 4.01-9.97%. Mean LH values were cal-
culated by averaging the results of the 25 blood samples drawn
every 15 min for 6 h. The pre- and postoperative sera from an
individual woman were analyzed in the same LH assay. The
standard curve was calibrated with the relevant international
reference preparation (68/40; Medical Research Council, Mill
Hill, London, England). Serum concentrations of E2 and PRL
were measured by RIA using commercial kits (NMS Pharma-
ceuticals, Inc., Newport Beach, CA; Techland, Liege, Belgium);
mean values were obtained by averaging the results of the 3
blood samples.
Analysis
Significant LH peaks were identified with the Pulsar pro-
gram (14), in connection with the MLAB system (15) running
on a Digital Dec-20 computer. Briefly, this program first per-
forms the baseline determination, taking into account possible
long trends in the experimental series; the peaks are secondarily
identified on the basis of both height and length. This is made
through an iterative process. The program allows the user to
define the value of some parameters that will be used for both
baseline and peak determinations. In the present study, the
width of the "smoothing window" (used for baseline definition)
was fixed at 720 min, and the following values of the G criteria
were used for peak identification: Gl = 3.8, G2 = 2.26, G3 =
1.56, G4 = 1.13, and G5 = 0.83. In these conditions, a variation
in the experimental series is identified as a peak provided that
such a variation exceeds 3.8 times the expected SD at this point
if it concerns one experimental point only, 2.26 times the
expected SD if it concerns two subsequent points, 1.56 times
the expected SD for three subsequent points, etc. The expected
SD at each concentration is computed by the program on the




As shown in Table 1, the patients' ages ranged from
19.7-37.2 yr [mean, 23.9 ± 5.7 (±SD) yr], and the duration
of amenorrhea ranged from 1-7 yr [mean, 3.9 ± 2.3
(±SD) yr]. In all patients, radiological examination
showed signs consistent with a microadenoma, which
was subsequently proven at operation. The tumors all
were less than 10 mm in diameter [mean, 7.8 ± 1.8 (±
SD) mm].
After operation, all women resumed normal menstrual
cycles, with serum progesterone concentrations ranging
from 4-28 ng/ml in the luteal phase. The first menses
occurred 3-6 weeks after adenomectomy. The women
had regular cycles during the follow-up (at least 1 yr).
Two women, who desired pregnancy before operation,
became pregnant and delivered a term baby.
Hormone data
As illustrated in Table 2, serum PRL concentrations
were elevated in all patients before surgery and decreased
significantly (P < 0.0005) to normal values (1-14 ng/ml)
by 8 days after operation. In addition, the mean PRL
level 6 months later [7.1 ± 1.6 (±SD) ng/ml] did not
differ from the mean level on the eighth postoperative
day (6.2 ± 2.4 ng/ml).
Preoperative serum E2 levels were similar to those seen
during the early follicular phase (14-90 pg/ml) in nor-
mally cycling women, except in patient 7 in whom the
level was slightly higher. The levels on the eighth post-
operative day were not significantly different from the
preoperative values.
Mean LH levels ranged from 0.24-9.9 mlU/ml before
operation and from 0.99-5.89 mlU/ml after operation.
There was no significant difference in pre- and postop-
erative mean values. The frequency of LH pulses was
low in all patients before surgery (zero to two peaks per
6 h). On the eighth postoperative day, a significant
increase (P < 0.05) in LH pulses was achieved in the
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FIG. 1. Pre- and postoperative serum LH concentrations in patient 2.
The start of a LH pulse is indicated by an arrow. A, Points included in
peaks. Baselines, as calculated by Pulsar, are shown ( ).
Discussion
It is now well established that the secretion of pituitary
gonadotropins is pulsatile in nature, that this pattern of
secretion is of functional significance (16), and that LH
pulsatility occurs in response to pulsatile GnRH release
from the hypothalamus (17). In normally cycling women,
the frequency of LH pulses varies with the stage of the
menstrual cycle (5,18-20).
Hyperprolactinemic amenorrheic women can have re-
duced frequency or absence of LH pulses (5-8), although
they also may have a heterogeneous pattern (21). Normal
LH pulsatility can be restored with bromocriptine treat-
ment, resulting in PRL normalization (6-8, 21). Since it
has been suggested that bromocriptine can directly affect
LH release (22), it is not possible to assert with certainty
that the restoration of LH pulsatility is exclusively due
to PRL normalization.
Another method to evaluate the role of hyperprolacti-
nemia in altering LH pulsatility would be to study LH
secretory patterns before and after successful removal of
prolactinomas. This method was applied in a recent
study (9). However, in this report, postoperative resto-
ration of LH pulsatility was documented 2-6 months
after surgery, but the women had already had one or
more normal menstrual cycles, inferring complete nor-
malization of ovarian function, so this result was ex-
pected.
The present study, undertaken in a homogeneous
group of amenorrheic hyperprolactinemic patients, eval-
uated the LH secretory pattern before operation for
microadenoma and 8 days after surgery. At this time, the
patients had normal PRL levels, but none had any
change in estrogen secretion. Consequently, a possible
role for estrogens in the restoration of LH pulsatility
could be excluded. In five of eight amenorrheic hyperpro-
lactinemic women, an increased frequency of LH pulsa-
tility was found 8 days after successful excision of pitui-
tary microadenoma compared to preoperative LH pat-
terns. These changes occurred after PRL normalization
and without any change in E2 concentrations. This find-
ing suggests that the preoperative impaired pulsatility of
LH secretion was a central effect of hyperprolactinemia.
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